You have 9 free searches left this month | for more free features.

Manage access program

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Liver Transplant Disorder, Self Efficacy, Quality of Life Trial (Intelligent Case Manage Platform (ICMP) and self-management

Not yet recruiting
  • Liver Transplant Disorder
  • +2 more
  • Intelligent Case Manage Platform (ICMP) and self-management program
  • (no location specified)
Jul 12, 2023

HELP Pain Training Program

Enrolling by invitation
  • Pain
  • HELP Pain Training Program
  • Grand Rapids, Michigan
    Michigan State University
Jan 13, 2023

What Affects Willingness to Self-manage a Pessary?

Recruiting
  • Prolapse; Female
  • Prolapse, Vaginal
  • Uncertain what intervention will be co-created
  • Manchester, United Kingdom
    Manchester University NHS Foundation Trust
Feb 28, 2023

Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer Trial (HER3-DXd)

Available
  • Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer
  • (no location specified)
Oct 17, 2023

SCA, Spinocerebellar Ataxias Trial (Troriluzole)

Available
  • SCA
  • Spinocerebellar Ataxias
  • (no location specified)
Sep 6, 2023

Relapsed/Refractory Acute Leukemia Trial (SNDX-5613)

Available
  • Relapsed/Refractory Acute Leukemia
  • (no location specified)
Jun 15, 2023

Paroxysmal Nocturnal Hemoglobinuria, PNH, Extravascular Hemolysis Trial (Danicopan)

Available
  • Paroxysmal Nocturnal Hemoglobinuria
  • +2 more
  • (no location specified)
Aug 1, 2023

Thrombotic Thrombocytopenic Purpura (TTP) Trial (TAK-755)

No longer available
  • Thrombotic Thrombocytopenic Purpura (TTP)
  • (no location specified)
Mar 3, 2023

FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia Trial (midostaurin)

Available
  • FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia
  • (no location specified)
Oct 18, 2022

Chronic Myeloid Leukemia Trial (Asciminib)

Available
  • Chronic Myeloid Leukemia
  • (no location specified)
Jan 17, 2023

Relapsed/Refractory Higher-Risk Myelodysplastic Syndrome, Relapsed/Refractory Acute Myeloid Leukemia Trial (Magrolimab)

Available
  • Relapsed/Refractory Higher-Risk Myelodysplastic Syndrome
  • Relapsed/Refractory Acute Myeloid Leukemia
  • Magrolimab
  • (no location specified)
Jan 18, 2023

Hunter Syndrome Trial (Idursulfase-IT)

Available
  • Hunter Syndrome
  • (no location specified)
Apr 6, 2023

Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)

Available
  • Clear Cell Renal Cell Carcinoma
  • 89Zr-DFO-girentuximab
  • Los Angeles, California
    UCLA
Oct 12, 2023

Ovarian Cancer in Expanded Access Program in Latin America

Not yet recruiting
  • Ovarian Cancer
  • Observational study
  • (no location specified)
May 4, 2023

Hypoparathyroidism Trial (Palopegteriparatide (TransCon PTH))

Available
  • Hypoparathyroidism
  • Palopegteriparatide (TransCon PTH)
  • (no location specified)
Jan 10, 2023

Monocarboxylate Transporter 8 Deficiency, Allan-Herndon-Dudley Syndrome Trial (Tiratricol)

Available
  • Monocarboxylate Transporter 8 Deficiency
  • Allan-Herndon-Dudley Syndrome
  • (no location specified)
Jun 9, 2023

Wilson Disease Trial (ALXN1840)

Available
  • Wilson Disease
  • (no location specified)
Jan 6, 2023

Metastatic Castration-resistant Prostate Cancer (mCRPC) Trial (177Lu-PSMA-617, PSMA-11)

No longer available
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 12, 2023

Polycythemia Vera Trial (Ruxolitinib)

Available
  • Polycythemia Vera
  • (no location specified)
Mar 7, 2022

Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer, Locally Advanced Unresectable Gastric

Available
  • Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer
  • +3 more
  • Morristown, New Jersey
    AMG Hematology/Oncology
Sep 15, 2023

Acute Myeloid Leukemia, MDS Trial (Galinpepimut-S)

Available
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Galinpepimut-S
  • (no location specified)
Oct 20, 2022

Relapsed or Refractory Multiple Myeloma Trial (Talquetamab)

Available
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Mar 6, 2023

COVID-19 Trial (Bamlanivimab)

No longer available
  • COVID-19
  • (no location specified)
Jan 16, 2023

Large B-cell Lymphoma, DLBCL, Not Otherwise Specified, Primary Mediastinal Large B-cell Lymphoma (PMBCL) Trial (Epcoritamab)

Available
  • Large B-cell Lymphoma
  • +4 more
  • Epcoritamab
  • (no location specified)
Feb 16, 2023

Low-grade Glioma Trial (Tovorafenib)

Available
  • Low-grade Glioma
  • (no location specified)
Feb 23, 2023